BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 7602831)

  • 21. Investigation chemotherapy in multimodality therapy of non-small cell lung cancer.
    Vokes EE
    Front Radiat Ther Oncol; 1992; 26():64-71. PubMed ID: 1324877
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of targeted agents in adjuvant therapy for non-small cell lung cancer.
    Kelly K
    Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5027s-5029s. PubMed ID: 16000608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can adjuvant chemotherapy improve survival in patients with early-stage, resected non-small-cell lung cancer?
    Azzoli CG
    Nat Clin Pract Oncol; 2005 Nov; 2(11):552-3. PubMed ID: 16270095
    [No Abstract]   [Full Text] [Related]  

  • 24. The current status of adjuvant chemotherapy for resected non-small cell lung cancer.
    Socinski MA
    Semin Oncol; 1999 Oct; 26(5 Suppl 15):27-33. PubMed ID: 10566608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adjuvant chemotherapy in the early stages of non-small cell bronchial cancers].
    Le Chevalier T
    Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S31-2. PubMed ID: 12538932
    [No Abstract]   [Full Text] [Related]  

  • 26. [Advances in the diagnosis and treatment of lung cancer. I. Management of non-small cell carcinoma].
    Spiro SG
    Pneumonol Pol; 1990; 58(4-5):239-43. PubMed ID: 2168045
    [No Abstract]   [Full Text] [Related]  

  • 27. Update in the treatment and molecular biology of non-small cell lung cancer.
    Erlich R; Levitt ML
    Compr Ther; 1995 Aug; 21(8):445-57. PubMed ID: 8536445
    [No Abstract]   [Full Text] [Related]  

  • 28. [Our experience with patients operated after neoadjuvant therapy].
    Juhász M; Egri G; Váradi C; Mészáros Z; Keszler P
    Magy Seb; 2004 Dec; 57(6):332-5. PubMed ID: 15803876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy for non-small-cell lung cancer--new horizons.
    Reed CE; Carlson LS; Schiff RD; Seymore CH; Thompson KA
    J S C Med Assoc; 1990 May; 86(5):270-4. PubMed ID: 2160565
    [No Abstract]   [Full Text] [Related]  

  • 30. The future of adjuvant chemotherapy for resected non-small cell lung cancer.
    Vansteenkiste JF; Schildermans RH
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):165-75. PubMed ID: 15757448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant chemotherapy in early-stage non-small cell lung cancer.
    Edelman MJ
    Expert Rev Anticancer Ther; 2001 Aug; 1(2):229-35. PubMed ID: 12113028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
    Bunn PA
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer.
    Johnson BE; Rabin MS
    Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5022s-5026s. PubMed ID: 16000607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Does chemotherapy improve the results of postoperative radiotherapy in completely resected stage II and IIIA non-small-cell bronchial cancer?].
    Baumann M
    Strahlenther Onkol; 2001 Apr; 177(4):220-1. PubMed ID: 11370558
    [No Abstract]   [Full Text] [Related]  

  • 35. [Multimodal therapy of small cell and non-small cell lung carcinoma].
    Serke M; Kollmeier J
    Dtsch Med Wochenschr; 2007 Jun; 132(22):1221-4. PubMed ID: 17520508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multidisciplinary management of lung cancer.
    Spira A; Ettinger DS
    N Engl J Med; 2004 Jan; 350(4):379-92. PubMed ID: 14736930
    [No Abstract]   [Full Text] [Related]  

  • 37. [Combined modality treatment of chemotherapy and radiotherapy for unresectable non-small cell lung cancer].
    Kubota K
    Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():384-9. PubMed ID: 9369912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial.
    Douillard JY; Rosell R; De Lena M; Riggi M; Hurteloup P; Mahe MA;
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):695-701. PubMed ID: 18439766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Specificities of resectable Stage III non-small-cell lung cancer].
    Thibout Y; Cortot A; Mornex F
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 3):4S5-4S7. PubMed ID: 15687985
    [No Abstract]   [Full Text] [Related]  

  • 40. Lung resection in a neoadjuvant protocol.
    Klein J; Král V; Neoral C; Bohanes T; Aujeský R; Kolek V; Grygárková I; Hajdúch M; Tichý T
    Med Sci Monit; 2000; 6(5):937-40. PubMed ID: 11208434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.